DPP4 and chronic obstructive pulmonary disease: This might explain why chronic obstructive pulmonary disease (COPD) patients attacked by MERS‐CoV had poor outcomes, since the expression of DPP4 was predominantly upregulated on type I pneumocytes in such patients.202, 208